Terms: = Bone cancer AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA AND Treatment
11 results:
1. Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer.
Sun J; Tian T; Wang N; Jing X; Qiu L; Cui H; Liu Z; Liu J; Yan L; Li D
Front Endocrinol (Lausanne); 2024; 15():1338420. PubMed ID: 38384968
[TBL] [Abstract] [Full Text] [Related]
2. Vaccination practices of pediatric oncologists from eight states.
van Thiel Berghuijs KM; Kaddas HK; Warner EL; Fair DB; Fluchel M; Knackstedt ED; Verma A; Kepka D; Green AL; Smitherman AB; Draper L; Johnson RH; Kirchhoff AC
BMC Health Serv Res; 2023 Nov; 23(1):1215. PubMed ID: 37932718
[TBL] [Abstract] [Full Text] [Related]
3. Advances in treatment of alveolar soft part sarcoma: an updated review.
Fujiwara T; Kunisada T; Nakata E; Nishida K; Yanai H; Nakamura T; Tanaka K; Ozaki T
Jpn J Clin Oncol; 2023 Nov; 53(11):1009-1018. PubMed ID: 37626447
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
[TBL] [Abstract] [Full Text] [Related]
5. Primary Alveolar Soft Part Sarcoma of bone: A Rare Occurrence in 8 Patients, Posing a Diagnostic Challenge.
Kaur R; Ramadwar M; Gulia A; Pruthi M; Rekhi B; Panjwani PK; Puri A; Nayak P; Bajpai J; Janu A
Arch Pathol Lab Med; 2022 Dec; 146(12):1514-1522. PubMed ID: 35438716
[TBL] [Abstract] [Full Text] [Related]
6. Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature.
Frezza AM; Ravi V; Lo Vullo S; Vincenzi B; Tolomeo F; Chen TW; Teterycz P; Baldi GG; Italiano A; Penel N; Brunello A; Duffaud F; Hindi N; Iwata S; Smrke A; Fedenko A; Gelderblom H; Van Der Graaf W; Vozy A; Connolly E; Grassi M; Benjamin RS; Broto JM; Grignani G; Jones RL; Kawai A; Tysarowski A; Mariani L; Casali PG; Stacchiotti S
Cancer Med; 2021 Apr; 10(8):2645-2659. PubMed ID: 33713582
[TBL] [Abstract] [Full Text] [Related]
7. Paediatric orbital alveolar soft part sarcoma recurrence during long-term follow-up: a report of 3 cases and a review of the literature.
Wang Y; Du B; Yang M; He W
BMC Ophthalmol; 2020 Feb; 20(1):60. PubMed ID: 32085747
[TBL] [Abstract] [Full Text] [Related]
8. Future directions in soft tissue sarcoma treatment.
Hall F; Villalobos V; Wilky B
Curr Probl Cancer; 2019 Aug; 43(4):300-307. PubMed ID: 31229264
[TBL] [Abstract] [Full Text] [Related]
9. Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of tfe3: European Organization for Research and treatment of cancer (EORTC) phase II trial 90101 'CREATE'.
Schöffski P; Wozniak A; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Gelderblom H; Italiano A; Lindner LH; Hennig I; Strauss S; Zakotnik B; Anthoney A; Albiges L; Blay JY; Reichardt P; Sufliarsky J; van der Graaf WTA; Debiec-Rychter M; Sciot R; Van Cann T; Marréaud S; Raveloarivahy T; Collette S; Stacchiotti S
Ann Oncol; 2018 Mar; 29(3):758-765. PubMed ID: 29216400
[TBL] [Abstract] [Full Text] [Related]
10. [Secondary tfe3-associated renal cell carcinoma in a child treated for Ewing sarcoma].
Fedhila Ben Ayed F; Rhayem S; Doghri R; Ben Hassine L; Khemiri M; Mrad K; Bellagha I; Barsaoui S
Arch Pediatr; 2016 Feb; 23(2):171-5. PubMed ID: 26702489
[TBL] [Abstract] [Full Text] [Related]
11. XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.
Hung CC; Pan CC; Lin CC; Lin AT; Chen KK; Chang YH
J Chin Med Assoc; 2011 Nov; 74(11):500-4. PubMed ID: 22100019
[TBL] [Abstract] [Full Text] [Related]
